We are live on ! Find out more
GCTK

GlucoTrack
GCTK

Delisted

GCTK was delisted on the 29th of October, 2026.

Back to rankings

17 hedge funds and large institutions have $187K invested in GlucoTrack in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,417% more capital inflows, than outflows

Capital inflows: $279K | Capital outflows: $11.1K

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

89% more funds holding

Funds holding: 9 → 17 (+8)

42.33% more ownership

Funds ownership: 15.81% → 58.14% (+42%)

Holders
17
Holders Change
+8
Holders Change %
+88.89%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HRT Financial
HRT Financial
New York
+$103K
2
Jane Street
Jane Street
New York
+$80.5K
3
Citadel Advisors
Citadel Advisors
Florida
+$49.9K
4
Virtu Financial
Virtu Financial
New York
+$11.7K
5
Granite Islands Private Wealth
Granite Islands Private Wealth
Connecticut
+$9.8K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$8.03K
2
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust
Pennsylvania
-$3.07K
3
Morgan Stanley
Morgan Stanley
New York
-$1

GCTK Hedge Fund Activity: Q2 2026 in Review

17 of the 8,372 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2026, worth a combined $187K — up 81% from $104K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GCTK positions and 1 closed out — a net gain of 8 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, adding an estimated $103K. The largest seller was Geode Capital Management, cutting an estimated $8.03K.

  • 17 institutional investors held GlucoTrack (GCTK) as of Q2 2026, up from 9 in Q1 2026.
  • Funds reported $187K of GlucoTrack stock for Q2 2026, up 81% quarter-over-quarter.
  • 9 funds opened new GlucoTrack positions in Q2 2026 and 1 closed out, a net change of +8 holders.
  • The largest GlucoTrack buyer in Q2 2026 was HRT Financial, an estimated $103K added.
  • The largest GlucoTrack seller in Q2 2026 was Geode Capital Management, an estimated $8.03K sold.

Based on aggregated 13F filings for Q2 2026.